Key Points
• Dr. Dana Lambert, a former hospital pharmacist, is pioneering research into cannabinoid medicine's potential.
• A new Oxford University Press study reveals that minor cannabinoids, CBC and CBG, significantly enhance silver's effectiveness against dangerous bacteria like MRSA, E. coli, and Pseudomonas, making it 64 times more potent.
• This research highlights cannabis's potential as a novel solution in the ongoing battle against antibiotic-resistant superbugs, an area where traditional pharmaceutical companies have struggled.
What This Means for DC
What this means for DC: As the District's cannabis market matures, this research underscores the growing scientific interest in the plant's therapeutic potential beyond recreational use. For DC residents and medical cannabis patients, it suggests future possibilities for cannabis-derived treatments in combating serious infections, potentially influencing local medical cannabis policy and product development towards a broader range of cannabinoid-focused therapies.
Original Source: High Times
Original headline: "Big Pharma Gave Up On Superbugs. This Pharmacist Asked The Cannabis Plant Instead."
Read original article at High Times